immunotherapyCAR-T cell therapyLD-XRTSalvage Radiation TherapyAtEzolizumab
…y to remodulate tumor stroma and restore or enhance response to immunotherapy in solid tumors.Methods In this work, we leverage ARTIDIS techn…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 361–420 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
Empirical antibiotic therapy4Epidural anaesthesia4Non-pharmacological interventions4Palliative radiotherapy4Preventive treatment4biologic treatment4colonoscopy4cytotoxic chemotherapy4endoscopic therapy4induction therapy4personalised medicine4ASMs4Adoptive immunotherapy4Anaesthesia4Flow diverters4Nerve blocks4antipsychotic treatment4corneal transplantation4coronary angiography4endoscopic mucosal resection4first-line chemotherapy4ketogenic diet4lumbar puncture4medical treatments4supportive measures4transfusions4vasopressor support4Cerebrospinal fluid (CSF) shunting4Chimeric Antigen Receptor T (CAR-T) cell therapy4Complete surgical excision4Continuous Positive Airway Pressure (CPAP) therapy4Coronary artery bypass grafting4FOLFIRINOX4Immunotherapy-related4Lifestyle modification4Multidisciplinary management4Pre-exposure prophylaxis4Systemic corticosteroids4Thoracic epidural analgesia4Transarterial chemoembolisation4Transcutaneous Electrical Nerve Stimulation4Vitamin A supplementation4Weight loss4adjuvant treatment4aneurysm treatment4anti-programmed cell death protein 1 therapy4antifungal therapy4antiseizure medication4chemotherapies4chronic disease management4closed reduction4device therapy4disease-modifying therapy4disease-modifying treatments4gastric decompression4gene therapies4intravenous corticosteroids4intravenous immunoglobulin therapy4multidrug therapy4neoadjuvant chemoradiotherapy4
Articles mentioning treatments
7,227 articles · page 4 of 603TACETAEDoxorubicinCancer Research UK
…ted 5 year survival of only 15% [BSG 2024, Cancer Research UK]. TACE and TAE are treatment options for intermediate BCLC stage disea…
SAPTanticoagulationdual antiplatelet therapyDAPTsingle antiplatelet therapyischemic strokeaspirin
… were treated with CAS and 88 with MM. The MM strategy included SAPT (44.3%), DAPT (45.5%), anticoagulation (6.8%), or SAPT plus ant…
Beyond auto-segmentation: the case for planning and dosimetry AI in head and neck radiation oncology
head and neck radiotherapyradiotherapyvolumetric modulated radiotherapyAdaptive radiotherapyIMRTHead and neck cancer
… consequential.63 This distinction is particularly important in head and neck radiotherapy, where small deviations in dose distribution can meaningfully a…
TAVIHeart Valve CentreSevere aortic stenosis
… treatment pathway for transcatheter aortic valve implantation (TAVI) traditionally relies on tertiary Heart Valve Centre workup. Ho…
PEPPrEPraltegravirHIV infectiontenofovir disoproxil fumarate/emtricitabine
…d completion of treatment.Results Seventy-six patients received PEP. Most were men (67.1%), with a median age of 32 years (IQR 22–4…
CRFASRFANumeric Rating Scalelow back pain
… primary endpoint—74.1% with CRFA and 64.7% with SRFA. Although CRFA showed numerically greater reductions in NRS pain scores from b…
acupunctureSTRICTAScopus
…multiple components. Transparent reporting about the details of acupuncture intervention and its implementation can contribute to a more co…
CEAcarotid artery stentingCAScarotid artery stenosisT2DM
…es in postoperative stroke or myocardial infarction.Conclusions CEA was associated with lower in-hospital mortality in type 2 diabe…
SurgeryembolizationMRIcSDH
…matoma (cSDH) is challenging, because of high recurrence rates. Surgery is mainstay but embolization of middle meningeal artery has sho…
TAETVETransvenous embolizationbrain AVMs
…; 5%CI:26%-58%)(P=0.624).Conclusion TVE was more effective than TAE in terms of angiographic results at 3–6 months. Morbidity was s…
immunotherapychemotherapyLDRTradiotherapySBRTStereotactic body radiotherapysintilimablung cancer
…ut challenges persist in achieving durable responses. Combining immunotherapy with radiotherapy has emerged as a promising strategy. Stereota…